Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure

Atherosclerosis

Volumn 158, Issue 1, 2001, Pages 195-198

  Aviram, Michael ^a   Dornfeld, Leslie ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; POLYPHENOL DERIVATIVE; RAMIPRIL; TANNIN DERIVATIVE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME INHIBITION; FEMALE; FRUIT JUICE; HUMAN; HYPERTENSION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

AGED; BEVERAGES; BLOOD PRESSURE; FEMALE; FRUIT; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A;

EID: 0034907584     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(01)00412-9     Document Type: Article

References (22)

1. Why a pomegranate?
2. Quantitative determination of the polyphenolic content of pomegranate peel
3. Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing
4. Pomegranate juice consumption reduces oxidative stress, low density lipoprotein modifications and platelet aggregation: Studies in the atherosclerotic apolipoprotein E deficient mice and in humans
5. Does paraoxonase play a role in susceptibility to cardiovascular disease?
6. Association of the rennin-sodium profile with the risk of myocardial infarction in patients with hypertension
7. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction
8. Blood pressure, stroke and coronary heart disease. Short-term reduction in blood pressure: Overview of randomized drug trials epidemiological content
9. Circulating versus local renin-angiotensin system in cardiovascular homeostasis
10. Angiotensin II stimulation of vascular smooth muscle cells
11. Low density lipoprotein isolated from patients with essential hypertension exhibits increased propensity for oxidation and enhanced uptake by macrophages: A possible role for angiotensin II
12. Inhibitors of angiotensin-converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids
13. Antiatherogenic effect of captopril in the Watanabe heritable hyperlipidemic rabbit
14. Angiotensin converting enzyme inhibition-induced changes in patterns of hemodynamics, aorta viscoelasticity, arterial histopathology and endothelial cholesterol fluxes of atherosclerotic minipigs
15. Treatment of hypertension with ascorbic acid
16. Combination oral antioxidant supplementation reduces blood pressure
17. Effect of hydrosoluble coenzyme Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease
18. Quantitative determination of the polyphenolic content of pomegranate peel
19. Antioxidants for hypertension
20. Inactivation of cytochrome P-450 3A4 by bergamottin, a component of grapefruit juice
21. Attenuation of atherosclerosis in apolipoprotein E deficient mice Ramipril is dissociated from its antihypertensive effect and from potentiation of bradykinin
22. The HOPE study: Demons the cardiovascular protection of Ramipril, a ACE inhibitor